Canada markets open in 3 hours 52 minutes

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2000+0.0100 (+0.46%)
At close: 04:00PM EDT
2.3400 +0.14 (+6.36%)
After hours: 06:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 34.67M
Enterprise Value 27.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.60
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.87

Trading Information

Stock Price History

Beta (5Y Monthly) -1.90
52-Week Change 3-20.29%
S&P500 52-Week Change 323.10%
52 Week High 38.8200
52 Week Low 31.1700
50-Day Moving Average 32.3843
200-Day Moving Average 32.8927

Share Statistics

Avg Vol (3 month) 389.79k
Avg Vol (10 day) 368.76k
Shares Outstanding 515.76M
Implied Shares Outstanding 615.84M
Float 813.35M
% Held by Insiders 115.20%
% Held by Institutions 111.89%
Shares Short (Apr 15, 2024) 4579.12k
Short Ratio (Apr 15, 2024) 45.6
Short % of Float (Apr 15, 2024) 44.34%
Short % of Shares Outstanding (Apr 15, 2024) 43.68%
Shares Short (prior month Mar 15, 2024) 4294.47k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-106.65%
Return on Equity (ttm)-243.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-14.58M
Diluted EPS (ttm)-1.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.47M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.53
Book Value Per Share (mrq)0.32

Cash Flow Statement

Operating Cash Flow (ttm)-9.8M
Levered Free Cash Flow (ttm)-4.33M